# TCF12

## Overview
TCF12 is a gene that encodes the transcription factor 12, a member of the basic helix-loop-helix (bHLH) family of transcription factors. This protein plays a pivotal role in regulating gene expression during various developmental processes, particularly in muscle and neural tissues. As a transcription factor, TCF12 is involved in the formation of heterodimers with other bHLH proteins, which is essential for its DNA binding and transcriptional regulatory functions. The gene is implicated in several critical biological pathways, including muscle differentiation, osteogenesis, and cancer progression. Mutations in TCF12 have been associated with a range of clinical conditions, such as coronal craniosynostosis, Kallmann Syndrome, and T-cell acute lymphoblastic leukemia, highlighting its importance in both normal development and disease (Sharma2013Mutations; Davis2020TCF12; Veiga2022Monoallelic).

## Structure


## Function
TCF12, a basic helix-loop-helix (bHLH) transcription factor, plays a critical role in regulating gene expression during development, particularly in muscle and neural tissues. In muscle development, TCF12 interacts with MYOD to maintain chromatin accessibility and promote the expression of myogenic genes, which are essential for muscle differentiation and regeneration (Wang2022Tcf12). TCF12 stabilizes the chromatin landscape, ensuring proper muscle cell fate determination and differentiation by modulating chromatin architecture (Wang2022Tcf12). The absence of TCF12 leads to impaired muscle development, reduced muscle size, and delayed muscle regeneration (Wang2022Tcf12).

In the context of bone marrow mesenchymal stem cells, TCF12 is involved in maintaining the undifferentiated state of these cells. Its expression decreases during osteogenic differentiation, and silencing TCF12 enhances the differentiation of these stem cells into osteoblasts, indicating its inhibitory role in osteogenesis (Yi2016Tcf12). TCF12 also influences the BMP and Erk1/2 signaling pathways, which are crucial for osteogenic differentiation (Yi2016Tcf12).

Overall, TCF12 is a versatile transcription factor that influences various cellular processes by forming heterodimers with other bHLH proteins, thereby affecting DNA binding and transcriptional activity.

## Clinical Significance
Mutations in the TCF12 gene are clinically significant as they are associated with several disorders. TCF12 mutations are a frequent cause of coronal craniosynostosis, a condition characterized by the premature fusion of the coronal sutures in the skull, leading to abnormal skull shape and potential developmental issues. These mutations often result in a loss-of-function mechanism and are found in a significant proportion of both bilateral and unilateral coronal synostosis cases (Sharma2013Mutations).

TCF12 haploinsufficiency is also linked to autosomal dominant Kallmann Syndrome (KS), a condition marked by anosmia and reproductive issues due to defects in GnRH neuron development. This highlights the gene's role in both cranial and reproductive axis development (Davis2020TCF12).

In addition, TCF12 alterations have been implicated in T-cell acute lymphoblastic leukemia (T-ALL). Monoallelic deletion of TCF12 reduces the requirement for NOTCH1 hyperactivation in T-ALL, suggesting a role in tumorigenesis. The gene's interactions with tumor suppressors like Cdkn1a further underscore its significance in cancer development (Veiga2022Monoallelic).

TCF12 mutations can also lead to intellectual disabilities and other developmental anomalies, as seen in cases involving complex chromosomal rearrangements and microdeletions (Le2014Maternal).

## Interactions
TCF12, a member of the basic helix-loop-helix (bHLH) family, participates in several significant protein interactions. In colorectal cancer, TCF12 functions as a transcriptional repressor of E-cadherin by forming complexes with Bmi1 and EZH2, components of the polycomb group-repressive complexes PRC1 and PRC2. This interaction is crucial for the repression of E-cadherin expression, which is associated with cancer metastasis (Lee2012TCF12). TCF12 directly binds to the E-cadherin promoter, as demonstrated by chromatin immunoprecipitation (ChIP) assays, indicating its role in transcriptional regulation (Lee2012TCF12).

In muscle cell development, TCF12 interacts with MYOD, a muscle regulatory factor, to maintain the chromatin landscape necessary for myogenic gene expression. This interaction is essential for the co-occupancy of genomic sites and the regulation of muscle-specific genes. TCF12 and MYOD co-bind to target genes, influencing chromatin accessibility and transcriptional profiles during myogenesis (Wang2022Tcf12). The interaction between TCF12 and MYOD is crucial for stabilizing chromatin conformation and maintaining myogenic gene expression, particularly in proliferating muscle stem cells (MuSCs) (Wang2022Tcf12).


## References


[1. (Sharma2013Mutations) Vikram P Sharma, Aimée L Fenwick, Mia S Brockop, Simon J McGowan, Jacqueline A C Goos, A Jeannette M Hoogeboom, Angela F Brady, Nu Owase Jeelani, Sally Ann Lynch, John B Mulliken, Dylan J Murray, Julie M Phipps, Elizabeth Sweeney, Susan E Tomkins, Louise C Wilson, Sophia Bennett, Richard J Cornall, John Broxholme, Alexander Kanapin, David Johnson, Steven A Wall, Peter J van der Spek, Irene M J Mathijssen, Robert E Maxson, Stephen R F Twigg, and Andrew O M Wilkie. Mutations in tcf12, encoding a basic helix-loop-helix partner of twist1, are a frequent cause of coronal craniosynostosis. Nature Genetics, 45(3):304–307, January 2013. URL: http://dx.doi.org/10.1038/ng.2531, doi:10.1038/ng.2531. This article has 169 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ng.2531)

[2. (Davis2020TCF12) Erica E Davis, Ravikumar Balasubramanian, Zachary A Kupchinsky, David L Keefe, Lacey Plummer, Kamal Khan, Blazej Meczekalski, Karen E Heath, Vanesa Lopez-Gonzalez, Mary J Ballesta-Martinez, Gomathi Margabanthu, Susan Price, James Greening, Raja Brauner, Irene Valenzuela, Ivon Cusco, Paula Fernandez-Alvarez, Margaret E Wierman, Taibo Li, Kasper Lage, Priscila Sales Barroso, Yee-Ming Chan, William F Crowley, and Nicholas Katsanis. Tcf12 haploinsufficiency causes autosomal dominant kallmann syndrome and reveals network-level interactions between causal loci. Human Molecular Genetics, 29(14):2435–2450, July 2020. URL: http://dx.doi.org/10.1093/hmg/ddaa120, doi:10.1093/hmg/ddaa120. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddaa120)

[3. (Yi2016Tcf12) Siqi Yi, Miao Yu, Shuang Yang, Richard J. Miron, and Yufeng Zhang. Tcf12, a member of basic helix-loop-helix transcription factors, mediates bone marrow mesenchymal stem cell osteogenic differentiation in vitro and in vivo. Stem Cells, 35(2):386–397, September 2016. URL: http://dx.doi.org/10.1002/stem.2491, doi:10.1002/stem.2491. This article has 48 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1002/stem.2491)

[4. (Veiga2022Monoallelic) Diogo F. T. Veiga, Mathieu Tremblay, Bastien Gerby, Sabine Herblot, André Haman, Patrick Gendron, Sébastien Lemieux, Juan Carlos Zúñiga-Pflücker, Josée Hébert, Joseph Paul Cohen, and Trang Hoang. Monoallelic heb/tcf12 deletion reduces the requirement for notch1 hyperactivation in t-cell acute lymphoblastic leukemia. Frontiers in Immunology, March 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.867443, doi:10.3389/fimmu.2022.867443. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.867443)

[5. (Le2014Maternal) Pauline Le Tanno, Brice Poreau, Francoise Devillard, Gaëlle Vieville, Florence Amblard, Pierre‐Simon Jouk, Véronique Satre, and Charles Coutton. Maternal complex chromosomal rearrangement leads to tcf12 microdeletion in a patient presenting with coronal craniosynostosis and intellectual disability. American Journal of Medical Genetics Part A, 164(6):1530–1536, March 2014. URL: http://dx.doi.org/10.1002/ajmg.a.36467, doi:10.1002/ajmg.a.36467. This article has 13 citations.](https://doi.org/10.1002/ajmg.a.36467)

[6. (Wang2022Tcf12) Sheng Wang, Yinlong Liao, Haoyuan Zhang, Yunqi Jiang, Zhelun Peng, Ruimin Ren, Xinyun Li, and Heng Wang. Tcf12 is required to sustain myogenic genes synergism with myod by remodelling the chromatin landscape. Communications Biology, November 2022. URL: http://dx.doi.org/10.1038/s42003-022-04176-0, doi:10.1038/s42003-022-04176-0. This article has 7 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-022-04176-0)

[7. (Lee2012TCF12) Chun-Chung Lee, Wei-Shone Chen, Chia-Chi Chen, Li-Li Chen, Yi-Shing Lin, Chi-Shuan Fan, and Tze-Sing Huang. Tcf12 protein functions as transcriptional repressor of e-cadherin, and its overexpression is correlated with metastasis of colorectal cancer. Journal of Biological Chemistry, 287(4):2798–2809, January 2012. URL: http://dx.doi.org/10.1074/jbc.m111.258947, doi:10.1074/jbc.m111.258947. This article has 91 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m111.258947)